Shankaracharya S

University of Massachusetts Medical School

H-index: 13

North America-United States

About Shankaracharya S

Shankaracharya S, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Massachusetts Medical School, specializes in the field of Whole Genome sequence analysis, Whole Exome sequence analysis, Disease risk prediction modeling, machine learning, NGS Analysis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia

ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function

Role of Lysosomal Gene Variants in Modulating GBA‐Associated Parkinson's Disease Risk

Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis

CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis

Ly6a Differential Expression in Blood–Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B

Shankaracharya S Information

University	University of Massachusetts Medical School
Position	MD Anderson cancer center birla institute of technology mesra
Citations(all)	1242
Citations(since 2020)	954
Cited By	651
hIndex(all)	13
hIndex(since 2020)	12
i10Index(all)	15
i10Index(since 2020)	12
Email	Access Email
University Profile Page	University of Massachusetts Medical School
Google Scholar	View Google Scholar Profile

Shankaracharya S Skills & Research Interests

Whole Genome sequence analysis

Whole Exome sequence analysis

Disease risk prediction modeling

machine learning

NGS Analysis

Top articles of Shankaracharya S

Title	Journal	Author(s)	Publication Date
Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia	Nature Communications	Salome Funes Jonathan Jung Del Hayden Gadd Michelle Mosqueda Jianjun Zhong ...	2024/3/20
ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function	Cell reports	Desiree M Baron Adam R Fenton Sara Saez-Atienzar Anthony Giampetruzzi Aparna Sreeram ...	2022/4/5
Role of Lysosomal Gene Variants in Modulating GBA‐Associated Parkinson's Disease Risk	Movement Disorders	Letizia Straniero Valeria Rimoldi Edoardo Monfrini Salvatore Bonvegna Giada Melistaccio ...	2022/6
Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis	Neuron	Ramita Dewan Ruth Chia Jinhui Ding Richard A Hickman Thor D Stein ...	2021/2/3
CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis	Brain	Carol Dobson-Stone Marianne Hallupp Hamideh Shahheydari Audrey MG Ragagnin Zac Chatterton ...	2020/3/1
Ly6a Differential Expression in Blood–Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B	Human gene therapy	Ana Rita Batista Oliver D King Christopher P Reardon Crystal Davis null Shankaracharya ...	2020/1/1